-transparent.png){kind=logo}
Conventional balloon angioplasty treatment of aorto-ostial stenoses in native coronary arteries and saphenous vein grafts is associated with a low primary success rate, a high complication rate and a high incidence of restenosis. The short-term outcome of Palmaz-Schatz stent implantation in aorto-ostial lesions was compared with that of balloon angioplasty. Thirteen patients underwent stent implantation for 13 de novo lesions (four in the left main coronary trunk, two in the right coronary artery, seven in the vein graft) between January 1994 and December 1995. Fourteen patients underwent balloon angioplasty for 14 de novo lesions (five in the left main coronary trunk, four in the right coronary artery, five in the vein graft between January 1986 and April 1992. Both groups had similar clinical characteristics. Initial success was obtained in all patients in the stent group, compared with 71% of the balloon angioplasty group. Insufficient dilation was the main cause for such failure in the balloon angioplasty group. Baseline reference diameters were similar (3.40 +/- 0.65 mm in the stent group vs 3.36 +/- 0.42 mm in the balloon angioplasty group) and there was no difference in baseline minimal luminal diameter (1.41 +/- 0.74 vs 1.08 +/- 0.56 mm). Minimal luminal diameter was significantly greater in the stent group than in the balloon angioplasty group at both post-procedure and follow-up examinations (post: 3.36 +/- 0.58 vs 2.69 +/- 0.45 mm, p < 0.01; follow-up: 2.33 +/- 0.96 vs 1.52 +/- 0.68 mm, p < 0.05). There was no subacute occlusion in either group. The overall angiographic restenosis rate (> 50% stenosis) was lower in the stent group (17%) than in the balloon angioplasty group: the restenosis rates of native lesions were 0% in the stent group and 40% in the balloon angioplasty group; those of saphenous vein graft lesions were 33% in the stent group and 50% in the balloon angioplasty group. Although the number of patients was limited, these results suggest that Palmaz-Schatz stent implantation may be a safe and effective strategy for treating aorto-ostial lesions in both native coronary arteries and saphenous vein grafts.
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
June 1993,
Catheterization and cardiovascular diagnosis,
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
February 1995,
Catheterization and cardiovascular diagnosis,
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
May 1992,
American heart journal,
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
September 1994,
European heart journal,
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
January 1995,
The Journal of invasive cardiology,
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
January 1995,
The American journal of cardiology,
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
July 1997,
The Journal of invasive cardiology,
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
February 1993,
The American journal of cardiology,
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
November 2016,
Microcirculation (New York, N.Y. : 1994),
M Yamasaki, and
K Hara, and
K Masaki, and
N Kobayashi, and
H Nakajima, and
K Kouzuma, and
F Saeki, and
T Tamura
September 1994,
British heart journal,
